{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:43:33Z","timestamp":1781347413338,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"vor","delay-in-days":57,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Organization for Health Research and Development","award":["91112002"],"award-info":[{"award-number":["91112002"]}]},{"name":"ZonMw-VIDI","award":["91712394"],"award-info":[{"award-number":["91712394"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.nicl.2018.02.030","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T02:17:40Z","timestamp":1520043460000},"page":"713-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-9322","authenticated-orcid":false,"given":"Geor","family":"Bakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vingerhoets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Boucherie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthan","family":"Caan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Eersels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2018.02.030_bb0005","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","article-title":"Prefrontal dopamine D1 receptors and working memory in schizophrenia","volume":"22","author":"Abi-Dargham","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2018.02.030_bb0010","series-title":"Comprehensive Assessment of Symptoms and History","first-page":"1987","author":"Andreasen","year":"2000"},{"key":"10.1016\/j.nicl.2018.02.030_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2967\/jnumed.114.147488","article-title":"123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo","volume":"56","author":"Bakker","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2018.02.030_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1192\/bjp.157.6.853","article-title":"The social functioning scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients","volume":"157","author":"Birchwood","year":"1990","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0030","first-page":"1332","article-title":"Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors","volume":"36","author":"Boundy","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2018.02.030_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0040","series-title":"Neuropsychological Test Automated Battery (CANTAB eclipse) Manual","author":"Cambridge Cognition","year":"2006"},{"key":"10.1016\/j.nicl.2018.02.030_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2012.06.051","article-title":"The NMDA receptor as a target for cognitive enhancement","volume":"64","author":"Collingridge","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0306-4522(87)90006-6","article-title":"Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain","volume":"20","author":"Cortes","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.nicl.2018.02.030_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mp.4000684","article-title":"Muscarinic1 and 2 receptor mRNA in the human caudate-putamen: no change in m1 mRNA in schizophrenia","volume":"5","author":"Dean","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0060","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/npp.2015.330","article-title":"Changes in BQCA allosteric modulation of [3H]NMS binding to human cortex within schizophrenia and by divalent cations","volume":"41","author":"Dean","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0065","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2018.02.030_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuron.2015.09.004","article-title":"The consolidation and transformation of memory","volume":"88","author":"Dudai","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nicl.2018.02.030_bb0075","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","article-title":"Central cholinergic systems and cognition","volume":"48","author":"Everitt","year":"1997","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2018.02.030_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nicl.2018.02.030_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nicl.2018.02.030_bb0095","first-page":"1","article-title":"Factorial validity, measurement equivalence and cognitive performance of the Cambridge neuropsychological test automated battery (CANTAB) between patients with first-episode psychosis and healthy volunteers","volume":"45","author":"Haring","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.nicl.2018.02.030_bb0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/schbul\/sbj011","article-title":"Negative symptoms and cognitive deficits: what is the nature of their relationship?","volume":"32","author":"Harvey","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.nicl.2018.02.030_bb0105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","article-title":"The role of acetylcholine in learning and memory","volume":"16","author":"Hasselmo","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0110","first-page":"1","article-title":"PROCESS: a versatile computational tool for observed variable mediation, moderation, and conditional process modeling","author":"Hayes","year":"2012","journal-title":"White Pap."},{"key":"10.1016\/j.nicl.2018.02.030_bb0115","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","article-title":"Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients","volume":"346","author":"Hietala","year":"1995","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.nicl.2018.02.030_bb0120","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nicl.2018.02.030_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mpr.1376","article-title":"Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses","volume":"22","author":"Jackson","year":"2013","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.nicl.2018.02.030_bb0130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","article-title":"Schizophrenia Is a Cognitive Illness","volume":"70","author":"Kahn","year":"2013","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.nicl.2018.02.030_bb0135","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/mp.2012.105","article-title":"Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?","volume":"17","author":"Kapur","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.nicl.2018.02.030_bb0145","first-page":"1","article-title":"Presynaptic dopamine capacity in patients with treatment resistant schizophrenia taking clozapine: An [18F]DOPA PET study","author":"Kim","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0150","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hbm.20599","article-title":"Evaluation of automated brain MR image segmentation and volumetry methods","volume":"30","author":"Klauschen","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nicl.2018.02.030_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s002130000679","article-title":"Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study","volume":"156","author":"Lavalaye","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0160","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nicl.2018.02.030_bb0165","first-page":"S230","article-title":"Xanomeline plus tropsium: a novel strategy to enhance pro-muscarinic efficacy and mitigate peripheral side effects","volume":"41","author":"Miller","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.nicl.2018.02.030_bb0175","series-title":"Imaging Muscarinic Cholinergic Receptors in Human Brain In Vivo With SPECT, [e231] 4-Lododexetimide, and [1231] 4 _ Lodolevetimide","first-page":"562","author":"Muller-gartner","year":"1992"},{"key":"10.1016\/j.nicl.2018.02.030_bb0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S1461145706006584","article-title":"Comparison of the in-vivo muscarinic cholinergic receptor availability in patients treated with clozapine and olanzapine","volume":"10","author":"Raedler","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0893-133X(99)00162-1","article-title":"In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia","volume":"23","author":"Raedler","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.160.1.118","article-title":"In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia","volume":"160","author":"Raedler","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.33588\/rn.5509.2012246","article-title":"Cognitive deficit in schizophrenia: MATRICS consensus cognitive battery","volume":"55","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2012","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0205","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/npp.2009.41","article-title":"Altered M1 muscarinic acetylcholine receptor (CHRM1)-G\u03b1q\/11 coupling in a schizophrenia endophenotype","volume":"34","author":"Salah-Uddin","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0210","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopsych.2006.08.050","article-title":"Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia","volume":"61","author":"Scarr","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0215","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/mp.2008.28","article-title":"Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia","volume":"14","author":"Scarr","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0220","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv042","article-title":"Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank","volume":"18","author":"Scarr","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0230","first-page":"721","article-title":"The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction","volume":"16","author":"Nathan","year":"2013","journal-title":"Int. J. Neuropharmacol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0235","first-page":"190","article-title":"Movement disorders and psychosis, a complex marriage","volume":"6","author":"Van Harten","year":"2015","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0240","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00213-014-3794-9","article-title":"Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers","volume":"232","author":"Veselinovi\u0107","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fpsyt.2013.00157","article-title":"Pharmacological interventions for the MATRICS cognitive domains in schizophrenia: what's the evidence?","volume":"4","author":"Vingerhoets","year":"2013","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2017.06.014","article-title":"The effect of the muscarinic M 1 receptor antagonist biperiden on cognition in medication free subjects with psychosis","author":"Vingerhoets","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nicl.2018.02.030_bb0255","series-title":"Wechsler Adult Intelligence Scale","first-page":"1","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.nicl.2018.02.030_bb0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nicl.2018.02.030_bb0265","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/appi.ajp.2008.07081242","article-title":"Premorbid IQ in schizophrenia: a meta-analytic review","volume":"165","author":"Woodberry","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nicl.2018.02.030_bb0270","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1124\/jpet.111.187856","article-title":"Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease","volume":"340","author":"Xiang","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158218300664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158218300664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:22:55Z","timestamp":1761970975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158218300664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":54,"alternative-id":["S2213158218300664"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2018.02.030","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2018.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}